seed
Stage
1
Investors
About
MetriTrack develops FDA-cleared computer-assisted breast ultrasound technology designed to improve cancer detection in women with dense breast tissue by providing standardized, reproducible, and precise breast volume mapping during ultrasound exams.
Explore MetriTrack's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.